Campbell & Co Investment Adviser’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,490	Closed	-$3.77M	–	1041
2025 Q4	$3.77M	Sell	9,490 -3,207	-25%	-$1.42M	0.18%	160
2025 Q3	$5.79M	Buy	+12,697	New	+$5.17M	0.44%	18
2025 Q1	–	Sell	-16,858	Closed	-$3.97M	–	1008
2024 Q4	$3.97M	Buy	+16,858	New	+$4.43M	0.31%	66
2024 Q2	–	Sell	-10,614	Closed	-$1.59M	–	1030
2024 Q1	$1.59M	Sell	10,614 -12,757	-55%	-$2.13M	0.14%	221
2023 Q4	$4.47M	Buy	+23,371	New	+$3.98M	0.4%	15
2022 Q4	–	Sell	-2,558	Closed	-$512K	–	752
2022 Q3	$512K	Sell	2,558 -2,983	-54%	-$569K	0.12%	307
2022 Q2	$808K	Buy	5,541 +2,689	+94%	+$381K	0.22%	127
2022 Q1	$466K	Buy	+2,852	New	+$435K	0.13%	303
2021 Q4	–	Sell	-1,300	Closed	-$245K	–	603
2021 Q3	$245K	Buy	+1,300	New	+$244K	0.08%	447
2018 Q3	–	Sell	-2,703	Closed	-$266K	–	391
2018 Q2	$266K	Buy	+2,703	New	+$268K	0.2%	235
2015 Q1	–	Sell	-6,652	Closed	-$645K	–	193
2014 Q4	$645K	Buy	+6,652	New	+$616K	0.4%	96